There are 16 Biotech ETFs which can be found in the following ETF.com analytics segments:
- Equity: Global Biotech
- Equity: U.S. Biotech
- Inverse Equity: U.S. Biotech
- Leveraged Equity: U.S. Biotech
The largest Biotech ETF is the iShares NASDAQ Biotechnology ETF (IBB) with $9.5 B in assets under management and an expense ratio of 0.47% with a trailing 12 month gain of 5.36%. The best-performing ETF over the last 12 months was the Direxion Daily S&P Biotech Bull 3X Shares (LABU) with a total return of 38.04%. The most-recent ETF launched was the Loncar Cancer Immunotherapy ETF (CNCR) in October 2015.